Product Pipeline

4SC’s product pipeline is focused on autoimmune and cancer indications and currently comprises six compounds in different development stages. All programmes are aimed at offering targeted therapy options to facilitate significant improvements in treating patients. Two of the compounds are already in several Phase II trials for different indications. This comprehensive and advanced product pipeline enables 4SC to position itself firmly as an interesting partner of pharmaceutical and global biotechnology companies.